Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: Effexor metabolite submitted for FDA approval

Posted by Sonny Liston on December 30, 2005, at 18:44:17

In reply to Re: Effexor metabolite submitted for FDA approval, posted by law663 on December 30, 2005, at 17:41:08

According to Pharmatimes, "studies presented at the American Society for Clinical Pharmacology and Therapeutics earlier this year showed that the sustained-release formulation of desvenlafaxine leads to higher blood levels of the active drug than the once-daily Effexor XR/ER formulation of venlafaxine, and had a lower tendency to cause nausea."

These are the main reported "advantages" over Effexor. Not much to write home about about.

In addition Pharmatimes notes "that desvenlafaxine is seen as a patent extension strategy for Wyeth as it defends its Effexor franchise."


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


[593537]

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:Sonny Liston thread:591573
URL: http://www.dr-bob.org/babble/20051221/msgs/593537.html